Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Consensus Rating of “Hold” from Analysts
by Sarita Garza · The Markets DailyShares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) have received an average recommendation of “Hold” from the four brokerages that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $4.00.
Several equities analysts recently commented on the stock. Weiss Ratings raised shares of Bioceres Crop Solutions from a “sell (d-)” rating to a “sell (d)” rating in a research note on Tuesday, May 26th. Wall Street Zen downgraded shares of Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research note on Saturday, April 4th.
Check Out Our Latest Report on Bioceres Crop Solutions
Bioceres Crop Solutions Stock Performance
NASDAQ BIOX opened at $0.44 on Wednesday. The company has a current ratio of 0.88, a quick ratio of 0.70 and a debt-to-equity ratio of 0.57. The firm has a market capitalization of $27.51 million, a price-to-earnings ratio of -0.11 and a beta of 0.39. The firm’s 50 day simple moving average is $0.49 and its 200 day simple moving average is $0.83. Bioceres Crop Solutions has a 1 year low of $0.35 and a 1 year high of $5.15.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.11). The firm had revenue of $39.40 million for the quarter, compared to analyst estimates of $54.50 million. Bioceres Crop Solutions had a negative return on equity of 33.97% and a negative net margin of 92.85%. As a group, research analysts expect that Bioceres Crop Solutions will post -0.16 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Bioceres Crop Solutions
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp lifted its stake in Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after purchasing an additional 5,339 shares during the last quarter. Bank of America Corp DE lifted its stake in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after purchasing an additional 3,735 shares during the last quarter. PDT Partners LLC lifted its stake in Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after purchasing an additional 10,449 shares during the last quarter. Virtu Financial LLC bought a new position in Bioceres Crop Solutions in the 3rd quarter valued at approximately $40,000. Finally, Invesco Ltd. bought a new position in Bioceres Crop Solutions in the 4th quarter valued at approximately $45,000. Institutional investors own 17.68% of the company’s stock.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.